T1 weighted imaging pre-post contrast Delta T1 quantification differentiates perfused and non-perfused regions of tumor tissue and allows for monitoring of tumor changes in patients treated with anti-angiogenesis agents.

References:

  • Warmuth, Carsten, Matthias Gunther, and Claus Zimmer. “Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.” Radiology 228.2 (2003): 523-532.
  • Jackson, Alan, and David L. Buckley. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Ed. Geoffrey JM Parker. Berlin: Springer, 2005.

Tools:

  • IB DeltaT1 – pre/post contrast analysis tool (Imaging Biometrics)

FDA cleared: FDA cleared

Company: Imaging Biometrics

Leave a Reply